Elisabeth Tournier-Lasserve Selected Research

Elisabeth Tournier-Lasserve Research Topics

Disease

7	CADASIL 01/2023 - 01/2003
6	Central Nervous System Cavernous Hemangioma 05/2024 - 06/2006
3	Moyamoya Disease (Moya-Moya Disease) 01/2023 - 06/2011
3	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 10/2021 - 01/2016
2	Cerebral Small Vessel Diseases 04/2024 - 10/2021
2	Migraine with Aura (Familial Hemiplegic Migraine) 09/2022 - 01/2007
2	Cerebral Hemorrhage 01/2020 - 04/2006
2	Ataxia (Dyssynergia) 02/2010 - 06/2008
2	Episodic Ataxia 02/2010 - 06/2008
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2023
1	Embolic Stroke 01/2023
1	Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos) 12/2022
1	Osteogenesis Imperfecta (Lobstein Disease) 12/2022
1	Stroke (Strokes) 09/2022
1	Alzheimer Disease (Alzheimer's Disease) 10/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2017
1	Seizures (Absence Seizure) 06/2015
1	Leukoencephalopathies 06/2014
1	Esophageal Achalasia (Megaesophagus) 03/2014
1	Hematuria 03/2014
1	Chorea (Rheumatic Chorea) 05/2013
1	Hemorrhage 12/2012
1	Ischemic Stroke 12/2012
1	Heart Diseases (Heart Disease) 12/2012
1	Neoplasms (Cancer) 06/2011
1	Down Syndrome (Down's Syndrome) 06/2011
1	Neurofibromatoses (Neurofibromatosis) 06/2011
1	Thoracic Aortic Aneurysm 06/2011
1	Porencephaly 05/2007
1	Wounds and Injuries (Trauma) 05/2007
1	Paresis (Hemiparesis) 05/2007
1	Craniocerebral Trauma (Head Injury) 05/2007
1	Hypercapnia 05/2005
1	Hypertension (High Blood Pressure) 05/2005
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2003

Drug/Important Bio-Agent (IBA)

5	Notch3 ReceptorIBA 01/2023 - 01/2003
4	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2015
3	Cysteine (L-Cysteine)FDA Link 01/2023 - 03/2008
3	Messenger RNA (mRNA)IBA 10/2021 - 01/2015
2	3' Untranslated Regions (3' UTR)IBA 04/2024 - 01/2016
2	Epidermal Growth Factor (EGF)IBA 09/2022 - 03/2008
2	AnticoagulantsIBA 12/2012 - 05/2007
2	Ion Channels (Ion Channel)IBA 02/2010 - 06/2008
2	Collagen Type IV (Type IV Collagen)IBA 05/2007 - 04/2006
1	Complementary DNA (cDNA)IBA 05/2024
1	RNA (Ribonucleic Acid)IBA 11/2023
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2023
1	KRIT1 ProteinIBA 01/2023
1	Chloride Channels (Chloride Channel)IBA 01/2023
1	CollagenIBA 12/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022
1	Codon (Codons)IBA 10/2021
1	Amyloid (Amyloid Fibrils)IBA 10/2021
1	indirubin-3'-monoximeIBA 01/2020
1	von Willebrand FactorIBA 01/2017
1	ApolipoproteinsIBA 01/2016
1	Apolipoproteins E (ApoE)IBA 01/2016
1	Contrast MediaIBA 06/2015
1	GadoliniumIBA 06/2015
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 06/2014
1	Soluble Guanylyl CyclaseIBA 03/2014
1	Creatine Kinase (Creatine Phosphokinase)IBA 03/2014
1	Caffeine (No Doz)FDA LinkGeneric 05/2013
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2012
1	Warfarin (Coumadin)FDA LinkGeneric 12/2012
1	1,3,4,6- tetra- O- acetyl- 2- azido- 2- deoxyglucopyranose (TAAD)IBA 06/2011
1	LigandsIBA 06/2009
1	Calcium Channels (Calcium Channel)IBA 01/2007
1	Retinaldehyde (Retinal)IBA 06/2006
1	Dihydrotachysterol (AT 10)IBA 05/2005
1	Acetazolamide (Diamox)FDA LinkGeneric 05/2005
1	Vasodilator Agents (Vasodilators)IBA 05/2005

Therapy/Procedure

2	Therapeutics 01/2023 - 12/2012
1	Radiotherapy 06/2011
1	Lasers (Laser) 05/2005